Skip to main content

Molecular Pathology of Soft Tissue and Bone Tumors

  • Chapter
  • First Online:
Molecular Surgical Pathology

Abstract

This chapter presents cytogenetic and molecular pathology of sarcomas, with emphasis on recurrent abnormalities that are characteristic features of individual cancer types. General concepts concerning biology, pathology, diagnostic techniques, and molecular diagnostic applications of cancers are presented in the beginning of the chapter. The second portion presents each of the major sarcoma types, in alphabetical order, with a specific structure: basic pathology, clinical features, molecular genetic pathology, and molecular diagnosis. Most of the tumors presented herein are soft tissue sarcomas, as few recurrent abnormalities have been established to have biologic and diagnostic significance in bone tumors. In contrast to other diseases and cancers presented in this textbook, sarcomas are more commonly associated with cytogenetic changes, as opposed to molecular changes. Nevertheless, a variety of approaches (e.g., classical cytogenetic analysis, fluorescence in situ hybridization, reverse-transcriptase polymerase chain reaction, immunohistochemistry) are presented, with strengths and weaknesses of each for clinical application in each tumor type, as appropriate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Readings

  • Antonescu CR. The role of genetic testing in soft tissue sarcoma. Histopathology. 2006;48:13–21.

    Article  PubMed  CAS  Google Scholar 

  • Antonescu CR, Nafa K, Segal NH, Dal Cin P, Ladanyi M. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res. 2006;12:5356–62.

    Google Scholar 

  • Antonescu CR, Dal Cin P, Nafa K, Teot LA, Surti U, Fletcher CD, et al. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2007;46:1051–60.

    Article  PubMed  CAS  Google Scholar 

  • Antonescu CR, Zhang L, Chang N, Pawel BR, Travis W, Rosenberg AE, et al. Novel EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of 66 cases, including soft tissue, bone and visceral lesions, showing common involvement of EWSR1 gene rearrangement. Genes Chromosomes Cancer. 2010;49:1114–24.

    Article  PubMed  CAS  Google Scholar 

  • Antonescu CR, Zhang L, Nielsen P, Rosenberg A, Dal Cin P, Fletcher CD. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor. Genes Chromosomes Cancer. 2011;50:757–64.

    Article  PubMed  CAS  Google Scholar 

  • Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750–61.

    Article  PubMed  Google Scholar 

  • Atlas of Genetics and Cytogenetics in Oncology and Haematology, http://www.infobiogen.fr/services/chromcancer/index.html. Barr FG, Ladanyi M. Sarcomas. In: Leonard DGB, editor. Diagnostic molecular pathology. Philadelphia: Saunders; 2003, p. 53–76.

  • Barr FG, Womer RB. Molecular diagnosis of ewing family tumors: too many fusions… ? J Mol Diagn. 2007;9:437–40.

    Article  PubMed  Google Scholar 

  • Bovée JV, Hogendoorn PC. Molecular pathology of sarcomas: concepts and clinical implications. Virchows Arch. 2010;456:193–9.

    Article  PubMed  Google Scholar 

  • Breitfield PP, Meyer WH. Rhabdomyosarcoma: new windows of opportunity. Oncologist. 2005;10:518–27.

    Article  Google Scholar 

  • Chang CC, Shidham VB. Molecular genetics of pediatric soft tissue tumors. J Mol Diagn. 2003;5:143–54.

    Article  PubMed  CAS  Google Scholar 

  • Fisher C. Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch. 2010;456:153–66.

    Article  PubMed  Google Scholar 

  • Guillou L, Benhattar J, Bonichon F, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004;22:4040–50.

    Article  PubMed  Google Scholar 

  • Jain S, Xu R, Prieto VG, Lee P. Molecular classification of soft tissue sarcomas and its clinical applications. Int J Clin Exp Pathol. 2010;3:416–28.

    PubMed  CAS  Google Scholar 

  • Lee CH, Ou W, Marino-Enriquez A, Zhu M, Myeda M, Wang YX, et al. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci USA. 2012;109:929–34.

    Article  PubMed  CAS  Google Scholar 

  • Lemm D, Mügge LO, Mentzel T, Höffken K. Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol. 2009;135:653–65.

    Article  PubMed  Google Scholar 

  • Lessnick SL, Kovar H, Houghton P. The molecular basis of sarcoma. Sarcoma. 2011;2011:864130.

    Article  PubMed  Google Scholar 

  • Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, et al. Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol. 2011;35:135–44.

    Article  PubMed  Google Scholar 

  • Mertens F, Fletcher CD, Antonescu CR, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85:408–15.

    Article  PubMed  CAS  Google Scholar 

  • O’Leary TJ, Frisman DM. Soft tissue and bones. In: O’Leary TJ, editor. Advanced diagnostic methods in pathology. Saunders: Philadelphia; 2003. p. 421–58.

    Google Scholar 

  • Ordóñez JL, Osuna D, García-Domínguez DJ, Amaral AT, Otero-Motta AP, Mackintosh C, et al. The clinical relevance of molecular genetics in soft tissue sarcomas. Adv Anat Pathol. 2010;17:162–81.

    Article  PubMed  Google Scholar 

  • Romeo S, Dei Tos AP. Soft tissue tumors associated with EWSR1 translocation. Virchows Arch. 2010;456:219–34.

    Article  PubMed  CAS  Google Scholar 

  • Romeo S, Dei Tos AP. Clinical application of molecular pathology in sarcomas. Curr Opin Oncol. 2011;23:379–84.

    Article  PubMed  CAS  Google Scholar 

  • Sankar S, Lessnick SL. Promiscuous partnerships in Ewing’s sarcoma. Cancer Genet. 2011;204:351–65.

    Article  PubMed  CAS  Google Scholar 

  • Sorensen PHB, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children’s oncology group. J Clin Oncol. 2002;20:2672–9.

    Article  PubMed  CAS  Google Scholar 

  • Storlazzi CT, Mertens F, Nascimento A, et al. Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. Hum Mol Genet. 2003;12:2349–58.

    Article  PubMed  CAS  Google Scholar 

  • Szuhai K, Ijszenga M, de Jong D, Karseladze A, Tanke HJ. Hogendoorn PC The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin Cancer Res. 2009;15(7):2259–68.

    Article  PubMed  CAS  Google Scholar 

  • Sumegi J, Streblow R, Frayer RW, Dal Cin P, Rosenberg A, Meloni-Ehrig A, et al. Recurrent (2;2) and (2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator (NCOA) family. Genes Chromosomes Cancer. 2010;49:224–36.

    PubMed  CAS  Google Scholar 

  • Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, et al. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med. 2011;3(98):98ra82.

    Article  PubMed  Google Scholar 

  • Taylor BS, Barretina J, Maki RG, Antonescu CR, Singer S, Ladanyi M. Advances in sarcoma genomics and new therapeutic targets. Nat Rev Cancer. 2011;11(8):541–57.

    Article  PubMed  CAS  Google Scholar 

  • Wang L, Motoi T, Khanin R, Socci N, Olshen A, Mertens F, et al. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012;51:127–39.

    Article  PubMed  CAS  Google Scholar 

  • Williamson D, Lu YJ, Gordon T, et al. Relationship between MYCN copy number and expression in ­rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype. J Clin Oncol. 2005;23:880–8.

    Article  PubMed  CAS  Google Scholar 

  • Xia SJ, Barr FG. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors. Eur J Cancer. 2005;41:2513–27.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lindeman, N.I., Cin, P.D. (2013). Molecular Pathology of Soft Tissue and Bone Tumors. In: Cheng, L., Eble, J. (eds) Molecular Surgical Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4900-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4900-3_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4899-0

  • Online ISBN: 978-1-4614-4900-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics